The results of studies showed that acrinathrin demonstrated low mammalian toxicity following acute oral, dermal or inhalation exposure. The results obtained support those already known for other pyrethroids in particular the cyano-pyrethroids.
No irritation was observed in the skin and eye of rabbits treated with acrinathrin technical, while very slight and reversible irritation was noted following treatment with WP formulation. No ocular irritation was observed with the diluted solution of WP formulation. Both acrinathrin technical and WP formulation were negative in skin sensitisation studies conducted by Maximization method.
Acrinathrin did not show mutagenic potential, was not oncogenic in rats and mice and did not affect reproduction of two generations in rats.
Acrinathrin exhibited no teratogenic potential in rats and rabbits.
Main effects observed in subchronic toxicity studies through chronic toxicity studies were the decrease of body weight gain and food consumption, and skin lesions seen at high dose levels in rats and mice dietary studies. The skin lesions persisted with an itching and scratching phenomenon due to paresthetic changes, which were considered to be related to the pharmacological property of acrinathrin and it seems probable that it is brought about by an action of the substance on sodium channels and depolarisation of the sensory nerves. The findings in the reproduction study indicate that the effects are reversible and result in no permanent changes.
Through these long term studies, the overall NOAEL for acrinathrin was determined to be 15ppm (2.49mg/kg/day) in the oncogenicity study in mice.
ARDENT
® 3% WP was registered by Japanese MAFF in 1995 as the insecticide with miticidal activity for various crops including vegetables, fruits, tea as well as ornamental. When used in accordance with label directions, acrinathrin and its formulation will not adversely affect human health.
抄録全体を表示